Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 30.3B | 25.1B | 22.7B | 26.4B |
Cost of revenue | 21.3B | 17.3B | 14.9B | 18.0B |
Gross profit | 8.9B | 7.8B | 7.8B | 8.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.5B | 3.6B | 3.5B | 3.3B |
Operating income | 3.2B | 2.2B | 2.3B | 3.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 29.7M | 29.8M | 26.2M | 33.3M |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 2.5B | 2.7B | 3.6B |
Tax provision | 732.1M | 584.4M | 629.3M | 835.7M |
Net income | 2.9B | 1.9B | 2.1B | 2.7B |
Basic EPS | — | 14.7 | 16.3 | 21.5 |
Diluted EPS | — | 14.7 | 16.3 | 21.5 |
Basic average shares | — | 127.0M | 127.1M | 127.0M |
Diluted average shares | — | 127.0M | 127.1M | 127.0M |
EBITDA | 4.6B | 3.4B | 3.6B | 4.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |